arrow
Y

Yi Zheng

浙江大学
H指数:15
被引数:1,520

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nonlinear association of the hemoglobin glycation index with all-cause and cardiovascular mortality: A community-based cohort study

血红蛋白糖化指数与全因和心血管死亡率之间的非线性关联:一项基于社区的研究

2025-11-070
PRE
NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study

NKG2D CAR-NK过继细胞免疫疗法联合或不联合PD-1阻断剂治疗转移性结直肠癌:一项探索性研究

2025-10-210
OA
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial

Tecotabart vedotin在Claudin 18.2阳性晚期胃/胃食管结合部癌中的研究:一项贝叶斯1/2期临床试验

2025-09-200
PRE
Spatially resolved C1QC+ macrophage-CD4+ T cell niche in colorectal cancer microenvironment: implications for immunotherapy response

结直肠癌微环境中空间分辨的C1QC macrophage-CD4 T细胞生态位: 对免疫治疗反应的影响

2025-07-010
OA
In-depth plasma proteomics reveals the dynamic changes and prognostic biomarkers for chimeric antigen receptor-glypican-3 T-cell therapy in patients with hepatocellular carcinoma

深度血浆蛋白质组学揭示了嵌合抗原受体-磷脂酰肌醇聚糖蛋白3 T细胞疗法在肝细胞癌患者中的动态变化和预后生物标志物

2025-01-010
PRE
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial

RUNX-3-expressing CAR T细胞靶向glypican-3治疗晚期肝癌患者: I期试验

2023-09-0121
OAAI